Skip to main content
SpringerLink
Log in

Blood Pressure

  • Chapter
Brackenridge’s Medical Selection of Life Risks

  • 65 Accesses

Abstract

The association of raised blood pressure with extra mortality has been known for many years. It is one of the areas where study of insured populations by insurance company doctors has helped clinical medicine appreciate the significance of an abnormal finding in apparently healthy people.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Pickering GW. High Blood Pressure. New York: Grune Stratum, 1968.

    Google Scholar 

  2. Hypertension prevalence and the status of awareness treatment and control in the United States: final report of the Subcommittee on Definition and Prevalence of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (1984). Arch Intern Med 1984; 1045.

    Google Scholar 

  3. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): BMJ 2004; 328.

    Google Scholar 

  4. Task force on blood pressure control in children: report of the second task force on blood pressure control in children. Pediatrics 1987; 79: 1.

    Google Scholar 

  5. Fletcher AP. The effects of weight reduction upon the blood-pressure of obese hypertensive women. QJM 1954; 23: 331.

    CAS  PubMed  Google Scholar 

  6. Hamilton M et al. The aetiology of essential hypertension. Clin Sci 1954; 13: 271.

    Google Scholar 

  7. Kannel WB. Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 1976; 37: 269.

    Article  CAS  PubMed  Google Scholar 

  8. Kannel WB. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res 1995; 18: 181.

    Article  CAS  PubMed  Google Scholar 

  9. Pickering TG et al. How common is white coat hypertension? JAMA 1988; 259: 225–8.

    Article  CAS  PubMed  Google Scholar 

  10. Blood Pressure Study 1925. New York: Actuarial Society of America/Association of Life Insurance Medical Directors of America, 1925.

    Google Scholar 

  11. Blood Pressure Study 1939. New York: Actuarial Society of America/Association of Life Insurance Medical Directors of America, 1940.

    Google Scholar 

  12. Build and Blood Pressure Study 1959. Chicago: Society of Actuaries, 1959.

    Google Scholar 

  13. Blood Pressure Study 1979. New York: Society of Actuaries/Association of Life Insurance Medical Directors of America, 1980.

    Google Scholar 

  14. Singer RB. Summary data (exposures, deaths, mortality ratios and excess death rates) for the separate standard and substandard experience of the 1979 blood pressure study. J Insur Med 1986; 18: 17–23.

    CAS  Google Scholar 

  15. Singer RB, Levinson L (eds). Medical Risks: Patterns of Mortality and Survival. Association of Life Insurance Medical Directors of America/Society of Actuaries, 1986.

    Google Scholar 

  16. Lew EA, Gajewski J (eds). Medical Risks: Trends in Mortality by Age and Time Elapsed. Association of Life Insurance Medical Directors of America, 1990.

    Google Scholar 

  17. Smith WMcF. Treatment of Mild Hypertension: results of a ten year intervention trial. USA Public Health Service Hospitals Cooperative Study, Group Circ Res 40 (Suppl 1) 1977: 98–105.

    Google Scholar 

  18. Helgeland MD. Treatment of mild hypertension: a 5 year controlled drug trial. The Oslo Study. Am J Med 1980; 69: 725–32.

    Article  CAS  PubMed  Google Scholar 

  19. Hypertension Detection and Follow-up Program Co-operative Group. The effect of treatment on mortality in mild hypertension. N Engl J Med 1983; 307: 976–80.

    Article  Google Scholar 

  20. Report by the management committee: the Australian therapeutic trial in mild hypertension. Lancet 1980; 1: 1261–7.

    Google Scholar 

  21. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial: risk factor changes and mortality results. JAMA 1982; 248: 1465–77.

    Article  Google Scholar 

  22. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291: 97–103.

    Article  Google Scholar 

  23. Amery A et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985; 1: 1349–54.

    Article  CAS  PubMed  Google Scholar 

  24. Savage DD et al. The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 1987; 75 (part II): 1.

    Google Scholar 

  25. Levy D et al. Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. Ann Intern Med 1988; 108: 7.

    Article  CAS  PubMed  Google Scholar 

  26. Messerli FH. Pathophysiology of essential hypertension and the role of combined alpha and beta blockade therapy. Dateline: Hypertension 1985; 3: 2.

    Google Scholar 

  27. Messerli FH. Essential hypertension in the elderly. Lancet 1983; 2: 983.

    Article  CAS  PubMed  Google Scholar 

  28. Savage D. Left ventricular hypertrophy as risk factor in sudden death (presented at 3rd Annual Meeting Am Soc of Hypertension). Medical Tribune 29 Sept 1988.

    Google Scholar 

  29. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993, 153: 154.

    Article  Google Scholar 

  30. Oparil S. Antihypertensive therapy-efficacy and quality of life (editorial). N Engl J Med 1993; 328: 959.

    Article  CAS  PubMed  Google Scholar 

  31. Gubner RS. Major new developments affecting treatment and prognosis in hypertension. Trans Assoc Life Insur Med Dir Am 1989: 73: 97–114.

    Google Scholar 

  32. Pollack AA, McGurl TJ, Plucinski TE. Hypertension in substandard insurance. Trans Assoc Life Insur Med Dir Am 1957; 41: 51.

    Google Scholar 

  33. Hines EA. Some aspects of the development and treatment of hypertensive diseaases. Trans Assoc Life Insur Med Dir Am 1955; 39: 25.

    Google Scholar 

  34. 16th International Conference of COINTRA 1989; 1: 33–43.

    Google Scholar 

  35. Ungerleider HE. The prognostic implications of the electrocardiogram. Am J Cardiol 1960; July: 35.

    Google Scholar 

  36. The 1988ReportoftheJointNationalCommitteeon Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1988; 148: 1023–38.

    Google Scholar 

Download references

Authors
  1. W John Elder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R D C Brackenridge
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Swiss Re Life & Health, London, UK

    R. D. C. Brackenridge MD FRCP (Glasg) (Consulting Medical Officer) & Richard S. Croxson MB FRACP (Cardiologist, Chief Medical Officer) (Consulting Medical Officer) &  (Cardiologist, Chief Medical Officer)

  2. Toronto General Hospital, Toronto, Ontario, Canada

    Ross MacKenzie MD, FRCP (C) FACC (Cardiologist) (Cardiologist)

Copyright information

© 2006 W John Elder

About this chapter

Cite this chapter

Elder, W.J., Brackenridge, R.D.C. (2006). Blood Pressure. In: Brackenridge, R.D.C., Croxson, R.S., MacKenzie, R. (eds) Brackenridge’s Medical Selection of Life Risks. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-56632-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-56632-7_19

  • Publisher Name: Palgrave Macmillan, London

  • Print ISBN: 978-1-349-56634-1

  • Online ISBN: 978-1-349-56632-7

  • eBook Packages: Palgrave History CollectionHistory (R0)

Publish with us

Policies and ethics

Search

Navigation